Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance

PURPOSE: Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment default and noncompliance among these patients. PATIENTS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Vijay M., Noronha, Vanita, Joshi, Amit, Muddu, Vamshi, Dhumal, Sachin, Bhattacharjee, Atanu, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2015
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539870/
https://www.ncbi.nlm.nih.gov/pubmed/28804775
http://dx.doi.org/10.1200/JGO.2015.000265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539870/
https://www.ncbi.nlm.nih.gov/pubmed/28804775
http://dx.doi.org/10.1200/JGO.2015.000265

Ejemplares similares